Conditions

According to research by the American Heart Association, pregnant women who develop gestational diabetes may be at an increased risk of developing atherosclerotic complications, such as heart disease, later in life…. 

Girls who were obese, as measured by BMI at age 11 had lower academic attainment at 11, 13 and 16 years when compared to those of a healthy weight….

An analysis of 25 population studies which focused on weight and included 4 million women, 16,000 of whom developed ovarian cancer. The report showed a dose-response relationship: a six percent increased risk of developing ovarian cancer for every 5-point increase in BMI….

New evidence suggests that increased intake of certain vitamins, including B vitamins, may play a role in the increased prevalence of obesity in recent years….

John Anderson, MD, gives us a brief introduction to himself and talks about how, as an internal medicine specialist, he deals with a whole range of issues related to diabetes which he see in his patients. More videos with John Anderson, MD: Thoughts on SGLT-2 Inhibitors What is the ADA …

John Anderson, MD, talks about the efforts of the American Diabetes Association, and how they are using the successful experiences they have gained through landmark studies such as the Diabetes Prevention Program (DPP), applying this knowledge to new initiatives such as outreach into the community through the YMCA and other …

John Anderson, MD, talks about how clinicians should look at more than just a specific A1c number when beginning treatment for diabetes explaining that the measure is really only a way to project future risk. Factors such as family history, ethnic background and other characteristics may be more relevant. But …

John Anderson, MD, talks about the new SGLT-2 inhibitors, what he has heard so far on their efficacy, and some of the concerns that have been raised about this new class of drugs…. See more SGLT-2 Resources More videos with John Anderson, MD: John Anderson, MD, ADA Board of Directors, …

Dr. Stanley Schwartz finishes up his slides series on the current state of the obesity epidemic and its relationship with diabetes. Topics covered in this set include a discussion of the newest drug therapies on the market including the incretins and the SGLT-2 inhibitors…. To download in PowerPoint (.ppt) format: Obesity …

Richard S. Beaser, MD This week’s excerpt covers the following topics: Knowing the options for treatment Determining medication selection Clinical markers for the dominant underlying pathophysiology The three stages to glucose patterns